I had the nanoknife treatment for my 3+4 Gleason cancer early May, 2022. Had MRI’s, 2-3 biopsies, but the perineal biopsy got to the bottom of the gland. I was told by the surgeon that my PSA should drop by 30%. My PSA before treatment was about 5.4. My first follow up PSA was actually an 80% drop to 1.24. Promising. My prostate gland is a normal size. From what I was told and found online, the nanoknife has the least side effect potential by a fair margin. Had mine done in the Chicago area.
So glad you commented. I have almost exactly your numbers. 1 - 3+4 out of 15 biopsy’s. 4 were 3+3 and the other 10 were benign. The 5 positive were all on the left side. PSA is 5.4. How are you doing now? I hope well.
@@MM-sf3rl Thank you. Treatment was May 2, 2022. Second PSA was about 1.5, which surgeon said was statistically negligible change from first. MRI showed no evidence of any more cancer. I have one more PSA I will do in March and then a biopsy in May (last biopsy I hope). Bladder recovered, some ED.
@@your_royal_highness Thank you so much for sharing. I know it’s difficult but you may have given me a little hope eight months into this (and hundreds of hours of research) and I had never heard of Nanoknife.
Thank you for this information. I am pleased to learn that with Gleason 4+3 Nanoknife can be offered as a treatment. I assume I will get more information at 3pm on Friday when I have the telephone appointment with a UCLH Focal Therapy team member. My main question is "Is hormone therapy necessary?"
Why not treat early cancer instead of waiting for cancer to become more aggressive? It would make men feel less anxiety, scared and their quality of life would be so much better after nanoknife if it works instead of radiation (possibly causing secondary cancer in the bladder or bowel) or prostectomy (incontinence and embarrassment, risk of hernia, atrophy, etc.
I’ve just had this at UCLH London. Very quick, no pain. The catheter was the most uncomfortable part.
I had the nanoknife treatment for my 3+4 Gleason cancer early May, 2022. Had MRI’s, 2-3 biopsies, but the perineal biopsy got to the bottom of the gland. I was told by the surgeon that my PSA should drop by 30%. My PSA before treatment was about 5.4. My first follow up PSA was actually an 80% drop to 1.24. Promising. My prostate gland is a normal size. From what I was told and found online, the nanoknife has the least side effect potential by a fair margin. Had mine done in the Chicago area.
So glad you commented. I have almost exactly your numbers. 1 - 3+4 out of 15 biopsy’s. 4 were 3+3 and the other 10 were benign. The 5 positive were all on the left side. PSA is 5.4. How are you doing now? I hope well.
What institute did you go to in Chicago.
@@MM-sf3rl Thank you. Treatment was May 2, 2022. Second PSA was about 1.5, which surgeon said was statistically negligible change from first. MRI showed no evidence of any more cancer. I have one more PSA I will do in March and then a biopsy in May (last biopsy I hope). Bladder recovered, some ED.
@@MM-sf3rl Duly Health, Dr. Ranko Miocinovic
@@your_royal_highness Thank you so much for sharing. I know it’s difficult but you may have given me a little hope eight months into this (and hundreds of hours of research) and I had never heard of Nanoknife.
Thank you for this information. I am pleased to learn that with Gleason 4+3 Nanoknife can be offered as a treatment. I assume I will get more information at 3pm on Friday when I have the telephone appointment with a UCLH Focal Therapy team member. My main question is "Is hormone therapy necessary?"
Can nanoknife be used for salvage therapy in the prostate? Can it be used for bone mets?
I don’t know. Perhaps not here in US (Germany maybe?). Bone Mets means metastization? Then no.
Why not treat early cancer instead of waiting for cancer to become more aggressive?
It would make men feel less anxiety, scared and their quality of life would be so much better after nanoknife if it works instead of radiation (possibly causing secondary cancer in the bladder or bowel) or prostectomy (incontinence and embarrassment, risk of hernia, atrophy, etc.